Novel Dry Hyaluronic Acid-Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis.
cystic fibrosis
hyaluronic acid
inhalable vancomycin
polyelectrolyte–drug complex
pulmonary infection
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
22 Mar 2024
22 Mar 2024
Historique:
received:
06
02
2024
revised:
12
03
2024
accepted:
19
03
2024
medline:
27
4
2024
pubmed:
27
4
2024
entrez:
27
4
2024
Statut:
epublish
Résumé
Polyelectrolyte-drug complexes are interesting alternatives to improve unfavorable drug properties. Vancomycin (VAN) is an antimicrobial used in the treatment of methicillin-resistant
Identifiants
pubmed: 38675098
pii: pharmaceutics16040436
doi: 10.3390/pharmaceutics16040436
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
ID : PICT 2017-3005 and 2020-1782
Organisme : Universidad Nacional de Córdoba
ID : SECyT-UNC, Consolidar 1, 2018-2022, N°: 32720220400365CB
Organisme : European Union
ID : Horizon 2020, RISE Marie Skłodowska-Curie grant agreement N° 101007804 (Micro4Nano)